Impact of colony-stimulating factors to reduce febrile neutropenic events in breast cancer patients receiving docetaxel plus cyclophosphamide chemotherapy-Reference-Cited by-同舟云学术

Impact of colony-stimulating factors to reduce febrile neutropenic events in breast cancer patients receiving docetaxel plus cyclophosphamide chemotherapy

Published:2010-03-17 Issue:4 Volume:19 Page:497-504
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Chan Alexandre,Fu Wing Hang,Shih Vivianne,Coyuco Jurja Chua,Tan Sze Huey,Ng Raymond

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-010-0843-8.pdf

Reference29 articles.

1. Iannucci A, Chan A Management and treatment of hematologic toxicities. In: Ignoffo RJ, Viele C, Ngo Z (eds) Oncology nursing-pharmacy handbook, 1st edn. Elsevier-Mosby

2. Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH (2006) Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 106:2258–2266

3. Smith TJ, Khatcheressian J, Lyman GH et al (2006) Update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol 24:3187–3205

4. Lyman GH (2005) Guidelines of the National Comprehensive Cancer Network on the use of myeloid growth factors with cancer chemotherapy: a review of the evidence. J Natl Compr Canc Netw 3:557–571

5. Kuderer NM, Dale DC, Crawford J, Lyman GH (2007) Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review. J Clin Oncol 25:3158–3167

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How Asian Breast Cancer Patients Experience Unequal Incidence of Chemotherapy Side Effects: A Look at Ethnic Disparities in Febrile Neutropenia Rates;Cancers;2023-07-12

2. Ethnic disparity in chemotherapy–induced febrile neutropenia incidence in Asian breast cancer patients: A retrospective cohort study;2023-03-27

3. Association between Breast Cancer Polygenic Risk Score and Chemotherapy-Induced Febrile Neutropenia: Null Results;Cancers;2022-05-31

4. Hematological adverse events in the management of glioblastoma;Journal of Neuro-Oncology;2021-11-24

5. BBCIC Research Network Analysis of First-Cycle Prophylactic G-CSF Use in Patients Treated With High–Neutropenia Risk Chemotherapy;Journal of the National Comprehensive Cancer Network;2021-08-16